[1] 俞力夫,代晓明,李逸松.mRNA差异表达与口腔鳞状细胞癌相关研究进展[J].口腔医学研究, 2016, 32(1)∶100-104 [2] Kiko T, Nakagawa K, Tsuduki T, et al. MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer's disease [J]. Journal of Alzheimers Disease Jad, 2014, 39(2)∶253-259 [3] Müller M, Kuiperij H B, Claassen J A, et al. MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid [J]. Neurobiology of Aging, 2014, 35(1)∶152-158 [4] Liu C J, Tsai M M, Tu H F, et al. miR-196a, Overexpression and miR-196a2, Gene Polymorphism Are Prognostic Predictors of Oral Carcinomas [J]. Annals of Surgical Oncology, 2013, 20(3)∶406-414 [5] Wu D, Xi Q Y, Cheng X, et al. miR-146a-5p inhibits TNF-α-induced adipogenesis via targeting insulin receptor in primary porcine adipocytes [J]. Journal of Lipid Research, 2016, 57(8)∶1360-1372 [6] Scapoli L, Palmieri A, Lo Muzio L, et al. MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression [J]. Int J Iminunopathol Pharmacol,2010,23(4)∶1229-1234 [7] 常粲然,杜军,李二红,等.microRNA-21在口腔鳞状细胞癌中的表达与预后关系[J].口腔医学研究,2015,31(9)∶927-930 [8] Yuwen DL1, Sheng BB, Liu J, et al. MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer [J]. Eur Rev Med Pharmacol Sci,2017 ,21(11)∶2650-2658 [9] Pauley K M, Stewart C M, Gauna A E, et al. Altered miR-146a expression in Sjögren's syndrome and its functional role in innate immunity [J]. European Journal of Immunology, 2011, 41(7)∶2029-2039 [10] Hung PS, Liu CJ, Chou CS, et al. miR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes [J]. PLoS One,2013,8(11)∶e79926 |